标普和纳斯达克内在价值 联系我们

Tabula Rasa HealthCare, Inc. TRHC NASDAQ

NASDAQ Global Market • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
23/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
-71.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Tabula Rasa HealthCare, Inc. (TRHC) .

本页证实的标准:

  • VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($3.00, 71.4%).
  • 分析师共识目标价 $3.00 (-71.4% 下行风险) — 分析师认为当前价格水平存在明显下行风险。

SharesGrow 综合评分: 23/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
23/100
SG Score
View full scorecard →
价值
10/100
Price-to-Earnings & upside
Proven by this page
未來
37/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
护城河
22/100
→ Income
成长
30/100
→ Income
收入
10/100
→ Income

估值概览 — TRHC

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.85
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.18
每股账面价值$0.00
每股营收$12.33
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$3.00 (-71.4%)

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2013 $-0.39 $25.14M $-3.87M -15.4%
2014 $-0.11 $48.43M $-1.11M -2.3%
2015 $-0.29 $70.04M $-2.86M -4.1%
2016 $-0.54 $94.06M $-6.25M -6.6%
2017 $0.68 $134.55M $14.3M 10.6%
2018 $-2.48 $204.27M $-47.27M -23.1%
2019 $-1.57 $284.71M $-32.44M -11.4%
2020 $-3.71 $297.22M $-80.97M -27.2%
2021 $-3.39 $331.26M $-79.06M -23.9%
2022 $-3.18 $299.52M $-77.33M -25.8%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言